about
Stress-Related Immune Markers in Depression: Implications for TreatmentMental Health Comorbidity in MS: Depression, Anxiety, and Bipolar Disorder.Managing Neuropsychological Impairment in Multiple Sclerosis: Pilot Study on a Standardized Metacognitive Intervention.Cognitive behavioural therapy for the treatment of depression in people with multiple sclerosis: a systematic review and meta-analysis.Depressive symptoms in multiple sclerosis from an in vivo study with TBSS.Comparing CESD-10, PHQ-9, and PROMIS depression instruments in individuals with multiple sclerosis.Linguistic and psychometric validation of the MSSS-88 questionnaire for patients with multiple sclerosis and spasticity in GermanyEffectiveness and tolerance of anti-inflammatory drugs' add-on therapy in major mental disorders: a systematic qualitative review.The evidence for a beneficial role of vitamin A in multiple sclerosis.The incidence and prevalence of psychiatric disorders in multiple sclerosis: a systematic review.Immunoglobulin-mediated neuro-cognitive impairment: new data and a comprehensive review.Towards automated detection of depression from brain structural magnetic resonance images.Symptom changes in multiple sclerosis following psychological interventions: a systematic review.Association between brain-derived neurotrophic factor genetic polymorphism Val66Met and susceptibility to bipolar disorder: a meta-analysis.Impact of natalizumab treatment on fatigue, mood, and aspects of cognition in relapsing-remitting multiple sclerosisDeciphering Depressive Mood in Relapsing-Remitting and Progressive Multiple Sclerosis and Its Consequence on Quality of Life.Prevalence of Depression and Anxiety among Patients with Multiple Sclerosis Attending the MS Clinic at Sheikh Khalifa Medical City, UAE: Cross-Sectional StudyThe efficacy of a Mindfulness Based Intervention for depressive symptoms in patients with Multiple Sclerosis and their caregivers: study protocol for a randomized controlled clinical trialDepressive Symptoms Correlate with Disability and Disease Course in Multiple Sclerosis Patients: An Italian Multi-Center Study Using the Beck Depression Inventory.Depression in multiple sclerosis: a review of assessment and treatment approaches in adult and pediatric populations.Glatiramer acetate in treatment of multiple sclerosis: a toolbox of random co-polymers for targeting inflammatory mechanisms of both the innate and adaptive immune system?The risk of developing depression when suffering from neurological diseasesThe Gap in the Current Research on the Link between Health Locus of Control and Multiple Sclerosis: Lessons and Insights from a Systematic Review.Treating Post-traumatic Stress Disorder in Patients with Multiple Sclerosis: A Randomized Controlled Trial Comparing the Efficacy of Eye Movement Desensitization and Reprocessing and Relaxation Therapy.Intracerebroventricular administration of lipopolysaccharide induces indoleamine-2,3-dioxygenase-dependent depression-like behaviors.Detection of altered hippocampal morphology in multiple sclerosis-associated depression using automated surface mesh modeling.Psychiatric manifestations in cerebrotendinous xanthomatosis.Major depression and multiple sclerosis - a case reportAn observational postmarketing safety registry of patients in the UK, Germany, and Switzerland who have been prescribed Sativex® (THC:CBD, nabiximols) oromucosal spray.Suicidal Behavior and Neurological Illnesses.Cognitive-constructivist Approach in Medical Settings: The Use of Personal Meaning Questionnaire for Neurological Patients' Personality Investigation.Management options in multiple sclerosis-associated fatigue.Behavioral interventions in multiple sclerosis: a biopsychosocial perspective.Association between spinocerebellar ataxias caused by glutamine expansion and psychiatric and neuropsychological signals - a literature review.Depressive syndromes in neurological disorders.Antidepressants for neuro-regeneration: from depression to Alzheimer's disease.Recommendations on diagnosis and treatment of depression in patients with multiple sclerosis.Work-related problems in multiple sclerosis: a literature review on its associates and determinants.Neuroinflammation in suicide: Toward a comprehensive model.The effect of executive function on stress, depression, anxiety, and quality of life in multiple sclerosis.
P2860
Q26771607-7B884CF3-D3C1-406C-B577-EBF182324D61Q30241221-4F21F237-8E06-4469-B2EC-3895C4C41C4FQ30409871-A8C778EB-2CE3-4DF6-8FC9-56FC68403CC8Q30564263-C6D80AC0-5D94-47FD-A706-D62FDCA42133Q33625308-5208B2B2-362F-4D1A-969D-4A2E14514B86Q33760818-A83E30D0-CD50-40FF-886E-2468AD924FB6Q34105894-D5A5E232-DE6A-4727-AD76-72B3657D8643Q34384181-72A14E4E-C218-4334-86AC-0AA1C681D342Q34405797-9809E937-AE47-4AC3-B40F-4CA5CDFC5F29Q34457934-C45BF43F-3575-4F0B-904B-EC2DC899747EQ34550430-14AD222D-8CFD-4545-9133-3B5AD7941125Q34556789-8F64ED30-4FC7-4BC7-B944-EF823566EE7CQ34622229-E460D985-24C5-4144-A77C-C6DF92F80A72Q34978960-ABC00672-1788-4DE9-A4C4-2F4E43DD9B25Q35591351-CD73EFF4-BD05-4B49-882D-235107C48D40Q35837308-6725C858-F192-4DEC-B84F-016F0FD7EB1BQ35882486-026495E8-01F5-4815-A9D2-5659756D7961Q35891823-EA3C2642-E3B1-406F-A888-129B88D265DEQ36134388-B503C1F4-50BC-4693-BCA8-0B2CBD79EF44Q36337359-02C591EA-EC83-4D3D-9A4F-E92B6506D8A3Q36432500-5E0F7E7A-C679-4579-B21D-B728F02F25C0Q36537496-837DAFC0-817A-405C-AEC8-2622E5A0923BQ36651308-44475935-B2D3-4371-A1C1-06E94F8B17F1Q36818747-656A8837-C477-483A-9A54-ED068BFBFD2EQ37071182-98C86DA9-D07B-4680-8675-397C48A89313Q37107165-7BD984CF-4713-4C3E-B48D-C4E33A82E4D3Q37201364-21DF6B2F-D7ED-4404-A3F7-3E7AE06A0121Q37206185-05E2E7AB-EAED-4C9F-B586-4BAADAAD3F3AQ37420740-CAB9C69F-E9B5-4ACB-882A-37EDAD367677Q37541970-27ACC15A-06BC-41E5-9E48-9A46C155114DQ37747237-942834A0-519C-4D8A-9490-E0A7587F2310Q37973392-269EB0D7-6D9E-47FD-98B1-9E8FDAFF30F7Q38049624-C0EB4DE9-86A7-4EF2-8D26-1940ED7B5131Q38120762-FF7C7FF9-BD7E-47A5-9C4B-DF98E79F2A3AQ38146845-67AAE614-4EC7-4DE0-85AE-6DE5167DA0C7Q38152966-477FC8B8-8F68-4485-8575-24B34D1E6C44Q38185639-9C28128A-4337-4295-AF22-9692EC43EF4DQ38554887-7E17509D-1368-43AE-B343-0AEA271313B4Q38557139-E4F9B0A3-9941-4B55-8519-B417325401A3Q39002824-A183350C-6CAD-442D-9D0E-AF995F748217
P2860
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Multiple sclerosis and depression.
@en
Multiple sclerosis and depression.
@nl
type
label
Multiple sclerosis and depression.
@en
Multiple sclerosis and depression.
@nl
prefLabel
Multiple sclerosis and depression.
@en
Multiple sclerosis and depression.
@nl
P2860
P356
P1476
Multiple sclerosis and depression.
@en
P2093
Anthony Feinstein
P2860
P304
P356
10.1177/1352458511417835
P577
2011-11-01T00:00:00Z